Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides

Bioorg Med Chem Lett. 1999 Mar 8;9(5):749-54. doi: 10.1016/s0960-894x(99)00073-6.

Abstract

Human beta3 adrenergic receptor agonists containing 5-membered ring ureas were shown to be potent partial agonists with excellent selectivity over beta1 and beta2 binding. L-760,087 (4a) and L-764,646 (5a) (beta3 EC50 = 18 and 14 nM, respectively) stimulate lipolysis in rhesus monkeys (ED50 = 0.2 and 0.1 mg/kg, respectively) with minimal effects on heart rate. Oral absorption in dogs is improved over other urea analogs.

MeSH terms

  • Administration, Oral
  • Adrenergic beta-1 Receptor Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists / chemical synthesis*
  • Adrenergic beta-Agonists / pharmacokinetics
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Dogs
  • Heart Rate / drug effects
  • Humans
  • Macaca mulatta
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / metabolism*
  • Receptors, Adrenergic, beta-3
  • Structure-Activity Relationship
  • Sulfonamides / chemical synthesis
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / pharmacology
  • Urea / analogs & derivatives
  • Urea / chemical synthesis
  • Urea / pharmacokinetics
  • Urea / pharmacology

Substances

  • Adrenergic beta-1 Receptor Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • L 755507
  • L 757793
  • L 760087
  • L 764646
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-3
  • Sulfonamides
  • Urea